Stemirna Therapeutics Co Ltd: mRNACOVID-19 Vaccine

Stemirna Therapeutics Co Ltd: mRNACOVID-19 Vaccine

Vaccine Type: RNA

About Trial Phases

Phase 1: 2 Trials

ChiCTR2100045984
China
NCT05144139
Lao People's Democratic Republic

Phase 2: 1 Trial

NCT05144139
Lao People's Democratic Republic

Phase 3: 0 Trials

There are no trials for this phase.

Approvals

This vaccine is not yet approved.

Registered Trials

NCT05144139
Phase 1/2
Lao People's Democratic Republic
Total Enrollment: 640
Official Trial Registration:
- NCT05144139(Opens in new tab/window)
ChiCTR2100045984
Phase 1
China
Total Enrollment: 240
Official Trial Registration:
- ChiCTR2100045984(Opens in new tab/window)

© 2022 VIPER Group COVID19 Vaccine Tracker Team

Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)

This site is provided for informational purposes only based on publically available data.

Site Credits Website Feedback Form